BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 36453776)

  • 1. Utility of PET-CT in Newly Diagnosed HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Lee J; Davis SJ; Amin SN; Rohde SL; Kim YJ
    Ann Otol Rhinol Laryngol; 2023 Oct; 132(10):1133-1139. PubMed ID: 36453776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PET/CT Poorly Predicts AJCC 8th Edition Pathologic Staging in HPV-Related Oropharyngeal Cancer.
    Snyder V; Goyal LK; Bowers EMR; Kubik M; Kim S; Ferris RL; Johnson JT; Duvvuri U; Gooding WE; Branstetter BF; Rath TJ; Sridharan SS
    Laryngoscope; 2021 Jul; 131(7):1535-1541. PubMed ID: 33428218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of quantitative (18)F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma.
    Schouten CS; Hakim S; Boellaard R; Bloemena E; Doornaert PA; Witte BI; Braakhuis BJ; Brakenhoff RH; Leemans CR; Hoekstra OS; de Bree R
    Head Neck; 2016 Apr; 38(4):529-35. PubMed ID: 25352335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retropharyngeal lymph node involvement in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Baxter M; Chan JY; Mydlarz WK; Labruzzo SV; Kiess A; Ha PK; Aygun N; Agrawal N
    Laryngoscope; 2015 Nov; 125(11):2503-8. PubMed ID: 26227748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective review of positron emission tomography with contrast-enhanced computed tomography in the posttreatment setting in human papillomavirus-associated oropharyngeal carcinoma.
    Chan JY; Sanguineti G; Richmon JD; Marur S; Gourin CG; Koch W; Chung CH; Quon H; Bishop JA; Aygun N; Agrawal N
    Arch Otolaryngol Head Neck Surg; 2012 Nov; 138(11):1040-6. PubMed ID: 23165378
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Jo KH; Kim J; Cho H; Kang WJ; Lee SK; Sohn B
    Yonsei Med J; 2023 Dec; 64(12):738-744. PubMed ID: 37992746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between radiologic and pathologic extranodal extension in HPV-associated oropharyngeal cancer: Systematic review.
    Morey T; Hodge JC; Stern C; Krishnan S; Foreman A
    Head Neck; 2022 Dec; 44(12):2875-2885. PubMed ID: 36071683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The negative predictive value of FDG PET/CT staging in early oropharyngeal squamous cell carcinoma and implications to transoral robotic surgery patient selection.
    Tapia M; Manji J; Dhillon K; Kleid S; Flatman S; Prasad J; Cardin A; Fua T; Rischin D; Dixon B; J R Magarey M
    Oral Oncol; 2022 Dec; 135():106213. PubMed ID: 36274346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Testing of a Machine Learning Model Using
    Woo C; Jo KH; Sohn B; Park K; Cho H; Kang WJ; Kim J; Lee SK
    Korean J Radiol; 2023 Jan; 24(1):51-61. PubMed ID: 36606620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttreatment surveillance PET/CT for HPV-associated oropharyngeal cancer.
    Corpman DW; Masroor F; Carpenter DM; Nayak S; Gurushanthaiah D; Wang KH
    Head Neck; 2019 Feb; 41(2):456-462. PubMed ID: 30549345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.
    Cheng NM; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Liao CT; Lin CY; Hsu CL; Yen TC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1673-84. PubMed ID: 22854984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
    Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
    Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of positron emission tomography/ computed tomography in the initial staging of head and neck squamous cell carcinoma: Accuracy in evaluation of the primary site of the tumor, metastases to cervical lymph nodes, and distant metastases.
    Krátká Z; Paska J; Kavka A; Jaruskova M; Lohynska R; Lickova K; Cocek A
    Otolaryngol Pol; 2022 Sep; 76(6):14-21. PubMed ID: 36805981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative 18F-FDG PET/CT and high-risk HPV in patients with oropharyngeal squamous cell carcinoma.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
    Head Neck; 2014 Mar; 36(3):323-7. PubMed ID: 23729374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Seventh and Eighth Edition of American Joint Committee on Cancer (AJCC) Staging for Selected and Nonselected Oropharyngeal Squamous Cell Carcinomas.
    Vijayvargiya P; Trivedi S; Rupji M; Song H; Liu Y; Jiang R; Kaka AS; Chen GZ; Stokes W; Steuer C; Shin DM; Beitler JJ; Patel MR; Aiken A; Saba NF
    Oncologist; 2022 Feb; 27(1):48-56. PubMed ID: 35305095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
    Muller RG; Weidenbecher M; Ludlow D
    Head Neck; 2022 May; 44(5):1164-1171. PubMed ID: 35212072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
    Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
    Kikuchi M; Koyasu S; Shinohara S; Usami Y; Imai Y; Hino M; Itoh K; Tona R; Kanazawa Y; Kishimoto I; Harada H; Naito Y
    Head Neck; 2015 Oct; 37(10):1524-31. PubMed ID: 24890445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 12 week PET-CT has low positive predictive value for nodal residual disease in human papillomavirus-positive oropharyngeal cancers.
    Rulach R; Zhou S; Hendry F; Stobo D; James A; Dempsey MF; Grose D; Lamb C; Schipani S; Rizwanullah M; Wilson C; Paterson C
    Oral Oncol; 2019 Oct; 97():76-81. PubMed ID: 31437587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of radiographically occult nodal metastases in HPV+ oropharyngeal carcinoma: Implications for reducing elective nodal coverage.
    Loganadane G; Kelly JR; Lee NC; Kann BH; Mahajan A; Hansen JE; Belkacémi Y; Yarbrough W; Husain ZA
    Pract Radiat Oncol; 2018; 8(6):397-403. PubMed ID: 29730282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.